First person treated with gene therapy targeting ageing cells
5 reported
According to a single-source report from The Guardian, the first person has been treated with a new gene therapy designed to reverse ageing in cells. The therapy targets retinal cells, aiming to encourage them to behave as if they were young again, which could improve sight in affected patients. If the treatment proves safe, it may lead to further therapies based on cellular rejuvenation. The report features comments from science editor Ian Sample and John Knoepfler, a professor of cell biology and human anatomy at the University of California, Davis.
What’s reported
The first person has been treated with a new gene therapy aimed at reversing ageing in cells.
The trial focuses on retinal cells to potentially improve sight.
The therapy hopes to make cells behave as if they were young again.
If safe, it could open the door to more therapies in cellular rejuvenation.
The report is from a single source, The Guardian, and has not been cross-referenced.
Key figures
Ian Sample, science editor (The Guardian)
John Knoepfler, professor of cell biology and human anatomy at the University of California, Davis
Sources: The Guardian
